{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:09:55Z","timestamp":1761808195235},"reference-count":26,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018,6,25]]},"DOI":"10.1253\/circj.cj-18-0114","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T18:31:57Z","timestamp":1524681117000},"page":"1874-1883","source":"Crossref","is-referenced-by-count":13,"title":["In-Hospital Bleeding and Utility of a Maintenance Dose of Prasugrel 2.5 mg in High Bleeding Risk Patients With Acute Coronary Syndrome"],"prefix":"10.1253","volume":"82","author":[{"given":"Masanobu","family":"Ohya","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenobu","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Osakada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimune","family":"Kuwayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidewo","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Otsuru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Habara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Fuku","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Katoh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. <i>N Engl J Med<\/i> 2007; 357: 2001\u20132015.","DOI":"10.1056\/NEJMoa0706482"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mehta RH, Cox M, Smith EE, Xian Y, Bhatt DL, Fonarow GC, et al. Race\/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy. <i>Stroke<\/i> 2014; 45: 2263\u20132269.","DOI":"10.1161\/STROKEAHA.114.005019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PLAFIT-ACS study. <i>Circ J<\/i> 2014; 78: 1684\u20131692.","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, et al. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: Risk scores from PARIS. <i>J Am Coll Cardiol<\/i> 2016; 67: 2224\u20132234.","DOI":"10.1016\/j.jacc.2016.02.064"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. <i>Lancet<\/i> 2017; 389: 1025\u20131034.","DOI":"10.1016\/S0140-6736(17)30397-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, et al. Validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. <i>Circulation<\/i> 2012; 125: 1424\u20131431.","DOI":"10.1161\/CIRCULATIONAHA.111.060871"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. <i>Circulation<\/i> 2007; 115: 2344\u20132351.","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, et al. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry. <i>Cardiovasc Interv Ther<\/i> 2013; 28: 162\u2013169.","DOI":"10.1007\/s12928-012-0146-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). <i>Circulation<\/i> 2010; 122: 52\u201361.","DOI":"10.1161\/CIRCULATIONAHA.109.903955"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. <i>JAMA<\/i> 2002; 288: 2411\u20132420.","DOI":"10.1001\/jama.288.19.2411"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakatsuma K, Shiomi H, Morimoto T, Ando K, Kadota K, Watanabe H, et al. Intravascular ultrasound guidance vs. angiographic guidance in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Long-term clinical outcomes from the CREDO-Kyoto AMI registry. <i>Circ J<\/i> 2016; 80: 477\u2013484.","DOI":"10.1253\/circj.CJ-15-0870"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation: A meta-analysis of randomized trials in the era of drug-eluting stents. <i>Circ Cardiovasc Interv<\/i> 2016; 9: e003700.","DOI":"10.1161\/CIRCINTERVENTIONS.116.003700"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. <i>Circulation<\/i> 2006; 114: 774\u2013782.","DOI":"10.1161\/CIRCULATIONAHA.106.612812"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY trial. <i>J Am Coll Cardiol<\/i> 2007; 49: 1362\u20131368.","DOI":"10.1016\/j.jacc.2007.02.027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, et al. Predictors of bleeding and time dependence of association of bleeding with mortality: Insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). <i>Circulation<\/i> 2011; 123: 2681\u20132689.","DOI":"10.1161\/CIRCULATIONAHA.110.002683"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nishikawa M, Isshiki T, Kimura T, Ogawa H, Yokoi H, Miyazaki S, et al. Risk of bleeding and repeated bleeding events in prasugrel-treated patients: A review of data from the Japanese PRASFIT studies. <i>Cardiovasc Interv Ther<\/i> 2017; 32: 93\u2013105.","DOI":"10.1007\/s12928-016-0452-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Valgimigli M, Saia F, Guastaroba P, Menozzi A, Magnavacchi P, Santarelli A, et al. Transradial versus transfemoral intervention for acute myocardial infarction: A propensity score-adjusted and -matched analysis from the REAL (REgistro regionale Angioplastiche dell\u2019Emilia-Romagna) multicenter registry. <i>JACC Cardiovasc Interv<\/i> 2012; 5: 23\u201335.","DOI":"10.1016\/j.jcin.2011.08.018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nishikawa M, et al. Impact of arterial access route on bleeding complications in Japanese patients undergoing percutaneous coronary intervention: Insight from the PRASFIT trial. <i>Circ J<\/i> 2015; 79: 1928\u20131937.","DOI":"10.1253\/circj.CJ-15-0276"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Genereux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. <i>J Am Coll Cardiol<\/i> 2015; 66: 1036\u20131045.","DOI":"10.1016\/j.jacc.2015.06.1323"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Navarese EP, Andreotti F, Schulze V, Kolodziejczak M, Buffon A, Brouwer M, et al. Optimal duration of dual antiplatelet thearpy after percutaneous coronary intervention with drug-eluting stents: Meta-analysis of randomised controlled trial. <i>BMJ<\/i> 2015; 350: h1618.","DOI":"10.1136\/bmj.h1618"},{"key":"21","unstructured":"21. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. <i>Circulation<\/i> 2016; 134: e123\u2013e155."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Bassez C, et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: The TOPIC (timing of platelet inhibitation after acute coronary syndrome) randomised study. <i>Eur Heart J<\/i> 2017; 38: 3070\u20133078.","DOI":"10.1093\/eurheartj\/ehx175"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wrishko RE, Ernest CS 2nd, Small DS, Li YG, Weerakkody GJ, Riesmeyer JR, et al. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38. <i>J Clin Pharmacol<\/i> 2009; 49: 984\u2013998.","DOI":"10.1177\/0091270009337942"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Small DS, Wrishko RE, Ernest CS 2nd, Ni L, Winters KJ, Farid NA, et al. Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. <i>J Clin Pharm Ther<\/i> 2009; 34: 585\u2013594.","DOI":"10.1111\/j.1365-2710.2009.01068.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kimura T, Isshiki T, Ogawa H, Yokoi H, Yamaguchi T, Ikeda Y. Randomized, double-blind, dose-finding, phase II study of prasugrel in japanese patients undergoing elective percutaneous coronary intervention. <i>J Atheroscler Thromb<\/i> 2015; 22: 557\u2013569.","DOI":"10.5551\/jat.26013"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/7\/82_CJ-18-0114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T22:39:14Z","timestamp":1571265554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/7\/82_CJ-18-0114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-0114","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]}}}